EPG Online Twitter 
EPG Online Blog 
Disease Knowledge Drug Updates
- Fostair 100/6 inhalation solution
- Epanutin capsules 25, 50 and 100mg
- Eprex 2000, 4000 and 10000 IU/ml solution for injection in pre-filled syringe
- FemSeven Conti
- Epanutin 300mg hard capsules
- Bedranol 80mg SR Capsules
- Bedranol 160mg SR Capsules
- Betim 10mg Tablets
- Carbo-Dome Cream
- Bisoprolol 2.5mg/5mg/10mg film coated tablet
- Phenergan Injection
- Rivotril 0.5 mg and 2 mgTablets
- Rivotril Ampoules
- RELPAX 20mg and 40mg Film-Coated Tablets
- Witch Doctor ® 81.5%w/w Gel
- Levetiracetam Actavis 1,000 mg film-coated tablets
- Levetiracetam Actavis 250 mg film-coated tablets
- Levetiracetam Actavis 500 mg film-coated tablets
- Levetiracetam Actavis 750 mg film-coated tablets
- Lidocaine Hydrochloride Injection BP 1% w/v plastic ampoules
- Lidocaine Hydrochloride Injection BP 2.0% w/v
- Omeprazole 10mg Capsules
- Omeprazole 20mg Capsules
- Panadol Extra Advance 500 mg/65 mg Tablets
- Allopurinol Tablets BP 300mg
- Allopurinol Tablets BP 100mg
- Anadin Ultra Double Strength 400mg Capsules/Anadin LiquiFast 400mg Capsules
- Calcipotriol Scalp Solution
- Bupivacaine Hydrochloride Injection BP 0.5% w/v.
- Lescol (fluvastatin* sodium) 20 mg and 40 mg capsules
- Meropenem 1 g Powder for Solution for Injection or Infusion
- VALTREX Tablets 250mg
- Vesicare 5mg & 10mg film-coated tablets
- Zomig 5mg Nasal Spray
- Water for Injections
- Tizanidine 2mg Tablets
- NovoRapid 100 U/ml in a vial, NovoRapid Penfill 100 U/ml, NovoRapid FlexPen 100 U/ml, NovoRapid FlexTouch 100 U/ml
- Orfadin 10 mg hard capsules
- Orfadin 2 mg hard capsules
- Natecal D3 Chewable Tablets
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
Anticholinergics.
Generic - eye
Eye ointment/eye drops.
Eye Ointment, atropine 1 per cent. Eye Drops, atropine 0.5 per cent , 1 per cent .
Treatment of iritis and uveitis to immobilise the iris and ciliary muscle and to prevent or break down adhesions. Used for refraction in children less than six years old and in children with convergent strabismus.
Uveitis/iritis: approximately half an inch of the ointment into the conjunctival sac once or twice a day or as directed by the physician/one or two drops to be instilled into the eye(s) to a maximum of 4 times daily.
Refraction: apply approximately half an inch of the ointment into the conjunctival sac one or two hours before refracting or as directed by the physician/one or two drops one hour before refracting. refracting.
Uveitis/iritis: approximately half an inch of the ointment into the conjunctival sac to a maximum of twice daily or as directed by the physician/one drop to be instilled into each eye to a maximum of 3 times daily. Refraction: approximately half an inch of the ointment into the conjunctival sac to a maximum of twice daily for 1 to 3 days prior to the examination, or as directed by the physician/one drop to be instilled into each eye twice daily for 1 - 3 days prior to the examination.
Use with caution.
Closed angle glaucoma. Patients with a narrow angle between the iris and the cornea. Known hypersensitivity to any component of the preparation, especially wool fat (ointment only).
Raised intraocular pressure. Contact lenses. May impair vision temporarily. Fever. Pregnancy and lactation. Tachycardia.
Photophobia. Prolonged use may lead to local irritation, hyperaemia, oedema and conjunctivitis. Increase in intra-ocular pressure may occur, especially in patients with closed angle glaucoma. Hypersensitivity.
Systemic toxicity may occur - reported symptoms include severe ataxia, restlessness, excitement and hallucinations. Other adverse effects may include a dry mouth with difficulty in swallowing and talking, flushing and a dry skin, transient bradycardia followed by tachycardia.
Martindale
(POM)
08 June 2009
